Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the improvement of other conditions in longer studies.

The new drugs could become the way forward for medicated weight loss as clinical trials reveal optimistic results ...

GoodRx reports transitioning from injectable to oral GLP-1s can simplify weight loss routines, but requires careful timing and consistency.

Type 2 diabetes medication Glucagon-like Peptide-1, also known as GLP-1, has grown into a popular weight loss treatment in the United States — however, some doctors are concerned with the ...

Glucagon is a peptide hormone secreted primarily from the alpha cells of the pancreatic islets of Langerhans. Minor amounts are also produced in the L cells of the intestine and certain neurons of the ...